6.
Fajnzylber J, Regan J, Coxen K, Corry H, Wong C, Rosenthal A
. SARS-CoV-2 viral load is associated with increased disease severity and mortality. Nat Commun. 2020; 11(1):5493.
PMC: 7603483.
DOI: 10.1038/s41467-020-19057-5.
View
7.
Puhach O, Adea K, Hulo N, Sattonnet P, Genecand C, Iten A
. Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2. Nat Med. 2022; 28(7):1491-1500.
DOI: 10.1038/s41591-022-01816-0.
View
8.
Butler D, Mozsary C, Meydan C, Foox J, Rosiene J, Shaiber A
. Shotgun transcriptome, spatial omics, and isothermal profiling of SARS-CoV-2 infection reveals unique host responses, viral diversification, and drug interactions. Nat Commun. 2021; 12(1):1660.
PMC: 7954844.
DOI: 10.1038/s41467-021-21361-7.
View
9.
Avadhanula V, Nicholson E, Ferlic-Stark L, Piedra F, Blunck B, Fragoso S
. Viral Load of Severe Acute Respiratory Syndrome Coronavirus 2 in Adults During the First and Second Wave of Coronavirus Disease 2019 Pandemic in Houston, Texas: The Potential of the Superspreader. J Infect Dis. 2021; 223(9):1528-1537.
PMC: 7928726.
DOI: 10.1093/infdis/jiab097.
View
10.
Mick E, Kamm J, Pisco A, Ratnasiri K, Babik J, Castaneda G
. Upper airway gene expression reveals suppressed immune responses to SARS-CoV-2 compared with other respiratory viruses. Nat Commun. 2020; 11(1):5854.
PMC: 7673985.
DOI: 10.1038/s41467-020-19587-y.
View
11.
Takahashi T, Ellingson M, Wong P, Israelow B, Lucas C, Klein J
. Sex differences in immune responses that underlie COVID-19 disease outcomes. Nature. 2020; 588(7837):315-320.
PMC: 7725931.
DOI: 10.1038/s41586-020-2700-3.
View
12.
To K, Tsang O, Leung W, Tam A, Wu T, Lung D
. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect Dis. 2020; 20(5):565-574.
PMC: 7158907.
DOI: 10.1016/S1473-3099(20)30196-1.
View
13.
Rouchka E, Chariker J, Alejandro B, Adcock R, Singhal R, Ramirez J
. Induction of interferon response by high viral loads at early stage infection may protect against severe outcomes in COVID-19 patients. Sci Rep. 2021; 11(1):15715.
PMC: 8333042.
DOI: 10.1038/s41598-021-95197-y.
View
14.
Travaglini K, Nabhan A, Penland L, Sinha R, Gillich A, Sit R
. A molecular cell atlas of the human lung from single-cell RNA sequencing. Nature. 2020; 587(7835):619-625.
PMC: 7704697.
DOI: 10.1038/s41586-020-2922-4.
View
15.
Saravia-Butler A, Schisler J, Taylor D, Beheshti A, Butler D, Meydan C
. Host transcriptional responses in nasal swabs identify potential SARS-CoV-2 infection in PCR negative patients. iScience. 2022; 25(11):105310.
PMC: 9540688.
DOI: 10.1016/j.isci.2022.105310.
View
16.
van Kampen J, van de Vijver D, Fraaij P, Haagmans B, Lamers M, Okba N
. Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19). Nat Commun. 2021; 12(1):267.
PMC: 7801729.
DOI: 10.1038/s41467-020-20568-4.
View
17.
Johnson W, Li C, Rabinovic A
. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics. 2006; 8(1):118-27.
DOI: 10.1093/biostatistics/kxj037.
View
18.
Huang D, Sherman B, Lempicki R
. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009; 4(1):44-57.
DOI: 10.1038/nprot.2008.211.
View
19.
Nicholson E, Schlegel C, Garofalo R, Mehta R, Scheffler M, Mei M
. Robust Cytokine and Chemokine Response in Nasopharyngeal Secretions: Association With Decreased Severity in Children With Physician Diagnosed Bronchiolitis. J Infect Dis. 2016; 214(4):649-55.
PMC: 4957440.
DOI: 10.1093/infdis/jiw191.
View
20.
Schultze J, Aschenbrenner A
. COVID-19 and the human innate immune system. Cell. 2021; 184(7):1671-1692.
PMC: 7885626.
DOI: 10.1016/j.cell.2021.02.029.
View